Probiotic Properties In Vitro of Bacillus velezensis FJAT-57093 with Antibacterial Activity Against the Aquatic Pathogen Aeromonas hydrophila

Yanping Chen, Suyi Li, Wenjie Li, Xuefang Zheng, M Chen, X. F. Liu, Jianglin Lan, Jieping WangMicroorganisms 2025 · DOI

TL;DR

This study identifies Bacillus velezensis FJAT-57093 as a promising probiotic candidate for aquaculture. It demonstrates potent in vitro antibacterial activity against the common aquatic pathogen Aeromonas hydrophila and other significant aquatic pathogens, alongside a suite of beneficial probiotic traits including gastrointestinal tolerance and antioxidant capabilities.

What Problem Does This Paper Address?

Aquaculture is a vital source of global protein, but bacterial diseases, particularly those caused by Aeromonas hydrophila, lead to significant mortality and economic losses. Traditional methods of disease control often rely on antibiotics, which contribute to the rise of antibiotic-resistant bacteria and pose risks to ecosystems and human health. There's a pressing need for effective, safe, and environmentally friendly alternatives. Probiotics, beneficial microorganisms that can improve host health and resist pathogens, are a promising solution. However, identifying and validating new probiotic strains with broad-spectrum efficacy and robust in vitro characteristics is crucial for their successful application in aquaculture.

Methods

The researchers screened 111 Bacillus-like strains for their ability to inhibit Aeromonas hydrophila using agar well diffusion assays. The most promising strain, Bacillus velezensis FJAT-57093, underwent a comprehensive in vitro evaluation. This included:

  • Antibacterial Spectrum: Testing against seven different aquatic pathogens.
  • Safety Assessment: Hemolytic activity assay and antibiotic susceptibility testing (Kirby-Bauer disk diffusion and MIC determination).
  • Genome Analysis: Whole-genome sequencing and annotation to predict virulence factors and antibiotic resistance genes (ARGs).
  • Metabolite Extraction: Acid precipitation to isolate and test antibacterial compounds.
  • Gastrointestinal Tolerance: Survival assays in simulated gastric and intestinal fluids at various pH levels.
  • Bile Salt Tolerance: Survival assays in the presence of different concentrations of bile salts.
  • Aggregation Abilities: Auto-aggregation and co-aggregation assays with target pathogens.
  • Antioxidant Activity: ABTS+ and DPPH radical scavenging assays.
  • Digestive Enzyme Production: Plate-based assays for amylase, protease, and cellulase activity.

Datasets

Not discussed in the paper. The study utilized bacterial strains isolated from various sources, including infected fish bodies and commercial suppliers, and compared genomic data against public databases like NCBI Non-Redundant Protein Database, Swiss-Prot, COG, GO, and KEGG.

Key Insights and Ideas

  • Acid Precipitation Yields Potent Antibacterials: The study found that compounds extracted from B. velezensis FJAT-57093 via acid precipitation were more potent antibacterials than the whole fermentation broth or cell-free supernatant, suggesting lipopeptides are key active metabolites.
  • Intrinsic Resistance, Not Transferable: Genomic analysis indicated that the identified antibiotic resistance genes (ARGs) and virulence factors were largely intrinsic to the FJAT-57093 genome, suggesting a lower risk of horizontal gene transfer and spread of resistance.
  • Robust Gastrointestinal Survival: The strain demonstrated remarkable resilience in simulated gastric and intestinal fluids, particularly recovering well after initial exposure to moderately acidic conditions (pH 3-4), highlighting its potential to survive transit through the digestive tract.
  • Extracellular Metabolites Drive Antioxidant Power: While bacterial cells showed some antioxidant activity, the cell-free supernatants exhibited significantly higher scavenging rates for ABTS+ and DPPH radicals, pointing to secreted compounds as the primary contributors.

Key Results

  • Strongest Inhibitor: B. velezensis FJAT-57093 showed the most potent antibacterial activity against Aeromonas hydrophila among 111 tested Bacillus-like strains, with an inhibition zone diameter of 20.83 mm.
  • Broad-Spectrum Activity: The strain also inhibited other significant aquatic pathogens, including Photobacterium damselae, Edwardsiella tarda, Vibrio parahaemolyticus, and Vibrio vulnificus.
  • Safety Profile: FJAT-57093 was non-hemolytic (y-hemolysis) and showed high or intermediate susceptibility to 10 out of 13 tested antibiotics, with resistance to streptomycin, penicillin G, and ampicillin being within acceptable limits based on MIC values and CLSI/EFSA guidelines.
  • Gastrointestinal Tolerance: Survival rates in simulated gastric fluid were 12.77% (pH 2), 14.65% (pH 3), and 67.09% (pH 4). After transfer to intestinal fluid (pH 6.8), survival increased to 67.26% (from pH 3) and 84.12% (from pH 4), though it remained low at 4.30% from pH 2.
  • Aggregation: The strain exhibited an auto-aggregation rate of 45.88% within 24 hours and co-aggregation rates with five aquatic pathogens ranging from 14.87% to 58.55%.
  • Antioxidant Capacity: Cell-free supernatants achieved ABTS+ and DPPH radical scavenging rates of up to 99.82% and 42.74%, respectively.
  • Enzyme Production: FJAT-57093 demonstrated the ability to produce amylase, protease, and cellulase, with hydrolytic zone diameters of 21.26, 16.85, and 9.23 mm, respectively.

Limitations and Future Work

The study acknowledges that while in vitro assessments are promising, further in vivo efficacy and safety evaluations are crucial. Key limitations and future directions include:

  • In Vivo Efficacy: The current study is limited to in vitro experiments. Future work must assess the strain's performance in live aquatic animals to confirm its probiotic benefits and protective effects against diseases.
  • Host Response and Ecological Impact: A comprehensive evaluation should also include understanding the strain's interaction with the host's immune system and its ecological impact within the farming environment.
  • Mechanism of Action: While lipopeptides are suggested as key antibacterial compounds, further detailed investigation into the specific mechanisms of action against various pathogens would be beneficial.
  • Long-Term Safety: While the in vitro safety assessment is positive, long-term in vivo studies are needed to fully confirm the absence of any adverse effects.

Summary updated

Abstract

The aim of this study was to acquire endospore-former(s) for aquatic animal feed based on the probiotic potential in vitro, including the anti-pathogen spectrum, gastrointestinal fluid tolerance, antioxidant activity, enzyme-producing ability, and basic safety assessment. The strain <i>Bacillus velezensis</i> FJAT-57093 was found to exhibit the strongest antibacterial ability against <i>Aeromonas hydrophila</i> in the agar well diffusion inhibition assays from 111 <i>Bacillus</i>-like strains. Moreover, the results showed that the compounds of the strain FJAT-57093 enriched by acid precipitation might be the main antibacterial metabolites. The strain FJAT-57093 also exhibited antibacterial effects against the aquatic pathogens <i>Photobacterium damselae</i>, <i>Edwardsiella tarda</i>, <i>Vibrio parahaemolyticus</i>, and <i>Vibrio vulnificus</i>. The safety assessment revealed that the strain FJAT-57093 was non-hemolytic and susceptible to ten antibiotics. The putative virulence and antibiotic resistance genes predicted were predominantly intrinsic to the FJAT-57093 genome. Furthermore, the strain FJAT-57093 demonstrated a tolerance of acid and bile salt under the simulated gastrointestinal tract conditions, extracellular enzyme-producing abilities, as well as an auto-aggregation rate of 45.88% at 24 h and co-aggregation rates with the aforementioned five aquatic pathogens, ranging from 14.87% to 58.55%. Additionally, its extracellular metabolites displayed strong antioxidant activities, with ABTS<sup>+</sup> and DPPH radical scavenging rates of up to 99.82% and 42.74%, respectively. In summary, the strain <i>B. velezensis</i> FJAT-57093 was found to possess strong antibacterial activities against multiple aquatic pathogens and desirable in vitro probiotic properties.
BibTeX
@inproceedings{chen2025probiotic,
  author = {Yanping Chen and Suyi Li and Wenjie Li and Xuefang Zheng and M Chen and X. F. Liu and Jianglin Lan and Jieping Wang},
  title = {{Probiotic Properties In Vitro of Bacillus velezensis FJAT-57093 with Antibacterial Activity Against the Aquatic Pathogen Aeromonas hydrophila}},
  booktitle = {Microorganisms},
  year = {2025},
  doi = {10.3390/microorganisms14010041},
}
Figure